Cedars Sinai Medical Group Beverly Hills, CA - 90211

Cedars Sinai Medical Group is categorized under Doctors in Beverly Hills, CA .

Cedars Sinai Medical Group was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Harvey Crystal, Owner at the company’s single location by writing to 250 North Robertson Boulevard # 603, Beverly Hills, California CA 90211 or by phoning (310) 385-3298. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cedars Sinai Medical Group
Contact Person: Harvey Crystal, Owner
Address: 250 North Robertson Boulevard # 603, Beverly Hills, California 90211
Phone Number: (310) 385-3298
Website Address: cedars-sinai.edu
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Cedars Sinai Medical Group was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Harvey Crystal, Owner for inquiries that concern Cedars Sinai Medical Group by calling the company number (310) 385-3298, as your correspondence is most welcome. Additionally, the physical location of the single location of Cedars Sinai Medical Group can be found at the coordinates 34.069461,-118.383655 as well as the street address 250 North Robertson Boulevard # 603 in Beverly Hills, California 90211.

For its online presence, you may visit Cedars Sinai Medical Group’s website at cedars-sinai.edu and engage with its social media outlets through on Twitter and on Facebook.